Hikma Pharmaceuticals Plc Block listing Interim Review

RNS Number : 4469G

Hikma Pharmaceuticals Plc

01 October 2024

 

Hikma Pharmaceuticals PLC

Block Listing Six Monthly Return

 

Date: 1 October 2024

 

Name of applicant:	Hikma Pharmaceuticals PLC
Name of scheme:	Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")
Period of return	From: 1 April 2024	To:	30 September 2024
Balance of unallotted securities under scheme(s) from previous return:	The Plans: 312,624 Ordinary Shares of 10 pence
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):	The Plans: 0 Ordinary Shares of 10 pence
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):	MIP: 1,194 Ordinary Shares of 10 pence EIP: 0 Ordinary Shares of 10 pence
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:	The Plans: 311,430 Ordinary Shares of 10 pence

 

Name of contact:	Helen Middlemist
Telephone number of contact:	[phone]

 

 

 

Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)

(LEI: 549300BNS685UXH4JI75)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BLRUPGWCUUPCURG